MedRx Co., Ltd (TYO: 4586)

Japan flag Japan · Delayed Price · Currency is JPY
91.00
0.00 (0.00%)
Oct 30, 2024, 1:59 PM JST
-38.51%
Market Cap 4.18B
Revenue (ttm) 254.00M
Net Income (ttm) -512.00M
Shares Out 46.95M
EPS (ttm) -13.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 375,500
Open 91.00
Previous Close 91.00
Day's Range 90.00 - 93.00
52-Week Range 80.00 - 199.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About MedRx

MedRx Co., Ltd, a pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan. The company develops medicines based on Ionic liquid transdermal system (ILTS) and Nano-sized Colloid Transdermal System (NCTS); and researches and develops painless transdermal administration system for vaccines, nucleic acid medicines, protein medicines, etc. Its products pipeline includes MRX-4TZT, which is in phase I clinical trials for the treatment of spastic paralysis; MRX-9FLT that is in ph... [Read more]

Sector Healthcare
Founded 2002
Employees 22
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4586
Full Company Profile

Financial Performance

In 2023, MedRx's revenue was 29.00 million, a decrease of -50.85% compared to the previous year's 59.00 million. Losses were -932.00 million, -16.11% less than in 2022.

Financial Statements

News

There is no news available yet.